110073-67-1

Basic information

• Product Name: Benzoic acid, 4-amino-3-ethenyl-, methyl ester
• CAS NO: 110073-67-1
• Molecular Formula: C10H11NO2
• Molecular Weight: 177.203
• Mol File: 110073-67-1.mol
• Article Data: 6

Chemical Properties

• CAS DataBase Reference: Benzoic acid, 4-amino-3-ethenyl-, methyl ester(CAS DataBase Reference)
• NIST Chemistry Reference: Benzoic acid, 4-amino-3-ethenyl-, methyl ester(110073-67-1)
• EPA Substance Registry System: Benzoic acid, 4-amino-3-ethenyl-, methyl ester(110073-67-1)

Safety Data

• Hazardous Substances Data: 110073-67-1(Hazardous Substances Data)

Upstream product

• 126759-33-9 methyl 3-ethenyl-4-nitrobenzoate 
• 19718-49-1 4-amino-3-iodobenzoic acid methyl ester 
• 7486-35-3 tri-n-butyl(vinyl)tin 
• 619-45-4 4-methoxycarbonyl aniline 
• 106896-49-5 methyl 4-amino-3-bromobenzoate 
• 6311-37-1 4-amino-3-bromo-benzoic acid 

Downstream Products

• 153304-75-7 4-amino-3-ethylbenzoic acid methyl ester 
• 1610957-81-7 C₂₄H₂₅NO₅ 
• 1610957-79-3 C₁₉H₁₇NO₃ 

Relevant articles and documents

Synthesis and biological evaluation of an antibacterial azaborine retinoid isostere

Our continued synthetic interest in this class of retinoids, CD437 and its analogs, against methicillin-resistant Staphylococcus aureus (MRSA) has brought us to explore further isosteric substitutions within the scaffold. Although our previous findings ha

Direct Tryptophols Synthesis from 2-Vinylanilines and Alkynes via C - C Triple Bond Cleavage and Dioxygen Activation

An unexpected metal-free C - C triple bond cleavage, dioxygen activation, and reassembly into tryptophol derivatives has been developed. This chemistry provides a novel, simple, and efficient approach to highly valuable tryptophol derivatives from simple substrates under mild conditions. The mechanistic studies may promote the discovery of new methodologies through C-C bond cleavage and dioxygen activation.

2-PHENYL-5-AMINO-1,3,4-OXADIAZOLES AND THEIR USE AS NICOTINIC ACETYLCHOLINE RECEPTOR LIGANDS

The present invention relates to novel oxadiazole derivatives of formula (1) having pharmacological activity, processes for their preparation, compositions containing them and their use in the treatment of neurological, psychiatric disorders and gastrointestinal disorders through modulation of the nicotinic α7 receptor formula (I).